4//SEC Filing
McKenna Mark C. 4
Accession 0000950170-24-084945
CIK 0001936258other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:31 PM ET
Size
5.4 KB
Accession
0000950170-24-084945
Insider Transaction Report
Form 4
McKenna Mark C.
Director
Transactions
- Award
Option (right to buy)
2024-07-17+72,500→ 72,500 totalExercise: $18.81Exp: 2034-07-17→ Ordinary Shares (72,500 underlying)
Footnotes (1)
- [F1]33% of the shares underlying the option will vest on July 17, 2025, the one-year anniversay of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for two years, subject to the Reporting Person's continued service through each such date.
Documents
Issuer
NewAmsterdam Pharma Co N.V.
CIK 0001936258
Entity typeother
Related Parties
1- filerCIK 0001749623
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 4:31 PM ET
- Size
- 5.4 KB